Updated: 15 March 2022
Products Covered: Spacelabs Patient Monitoring Products
Axeda “Access:7” Vulnerability Assessment and Potential Product Impact Statement
Spacelabs is currently monitoring developments and updates related to a recently published CISA and FDA Advisory concerning PTC’s Axeda Agent and Axeda Desktop Server vulnerabilities.
- Additional Resources
|PTC Article CS363561. Security vulnerabilities identified in the Axeda agent and Axeda Desktop Server
|CISA ICS Advisory on “Access:7” Vulnerabilities
|FDA Cybersecurity Alert on PTC Axeda Agent and Axeda Server
The information presented above is subject to change without notice. In no event will Spacelabs or any of its suppliers be liable for direct, indirect, special, incidental or consequential damages of any nature or kind arising from the use of this document, even if Spacelabs or its suppliers have been advised of the possibility of such damages.